Valeria Giandomenico

Valeria Giandomenico

Uppsala, C, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Gallein, a Gβγ subunit signalling inhibitor, inhibits metastatic spread of tumour cells expressing OR51E2 and exposed to its odorant ligand.

Gallein, a Gβγ subunit signalling inhibitor, inhibits metastatic spread of tumour cells expressing OR51E2 and exposed to its odorant ligand.

Journal: BMC research notes

Published: June 23, 2017

Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer.

Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine Cancer.

Journal: Neuroendocrinology

Published: March 14, 2016

Other Novel Therapies: Biomarkers, microRNAs and microRNA Inhibitors, DNA Methylation, Epigenetics, Immunotherapy and Virotherapy.

Other Novel Therapies: Biomarkers, microRNAs and microRNA Inhibitors, DNA Methylation, Epigenetics, Immunotherapy and Virotherapy.

Journal: Frontiers of hormone research

Published: August 26, 2015

Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.

Somatostatin Analogs Treated Small Intestinal Neuroendocrine Tumor Patients Circulating MicroRNAs.

Journal: PloS one

Published: February 10, 2015

Roles of miR-196a on gene regulation of neuroendocrine tumor cells.

Roles of miR-196a on gene regulation of neuroendocrine tumor cells.

Journal: Molecular and cellular endocrinology

Published: August 14, 2014

Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components.

Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components.

Journal: Neuroendocrinology

Published: July 17, 2014

Olfactory receptor 51E1 as a novel target for diagnosis in somatostatin receptor-negative lung carcinoids.

Olfactory receptor 51E1 as a novel target for diagnosis in somatostatin receptor-negative lung carcinoids.

Journal: Journal of molecular endocrinology

Published: August 24, 2013

Identification of candidate serum proteins for classifying well-differentiated small intestinal neuroendocrine tumors.

Identification of candidate serum proteins for classifying well-differentiated small intestinal neuroendocrine tumors.

Journal: PloS one

Published: January 23, 2013

Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.

Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: January 19, 2013

Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.

Olfactory receptor 51E1 protein as a potential novel tissue biomarker for small intestine neuroendocrine carcinomas.

Journal: European journal of endocrinology

Published: November 28, 2012

Improving the diagnosis and management of neuroendocrine tumors: utilizing new advances in biomarker and molecular imaging science.

Improving the diagnosis and management of neuroendocrine tumors: utilizing new advances in biomarker and molecular imaging science.

Journal: Neuroendocrinology

Published: August 20, 2012

The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells.

The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells.

Journal: PloS one

Published: July 20, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026